Log in to save to my catalogue

The Role of Bone Morphogenetic Protein Signaling in Non-Alcoholic Fatty Liver Disease

The Role of Bone Morphogenetic Protein Signaling in Non-Alcoholic Fatty Liver Disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0b2d4d623f694b79a8b273377b95590c

The Role of Bone Morphogenetic Protein Signaling in Non-Alcoholic Fatty Liver Disease

About this item

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Non-alcoholic fatty liver disease (NAFLD) affects over 30% of adults in the United States. Bone morphogenetic protein (BMP) signaling is known to contribute to hepatic fibrosis, but the role of BMP signaling in the development of NAFLD is unclear. In this study, treatment with either of two BMP inhibitors reduced hepatic triglyceride content in dia...

Alternative Titles

Full title

The Role of Bone Morphogenetic Protein Signaling in Non-Alcoholic Fatty Liver Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0b2d4d623f694b79a8b273377b95590c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0b2d4d623f694b79a8b273377b95590c

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-020-66770-8

How to access this item